Menu
1 min read · estimated
APPROVED USE
What FDA approved
For adults with metastatic NSCLC and an FDA test-confirmed RET fusion.
LAMPGEN ANALYSIS
Why it matters
The action converted the lung cancer accelerated approval to traditional approval.
What research teams should watch
Apply the conversion to the NSCLC indication and retain separate records for other RET-defined uses.
PRIMARY RECORDS